First Wave Bio
Boca Raton
About First Wave Bio
First Wave Bio develops medical solutions to address the lack of effective and safe treatments for Inflammatory Bowel Disease (IBD). The solutions include a gut-restricted small molecule that can be formulated for either oral or rectal administration to treat ulcerative colitis among other IBDs, giving UC patients more accessible and cost-effective treatment.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.6M
- Funding stage: M&A
- Last round: Series Unknown (Sep 2018)
- Website: firstwavebio.com
Industries & Categories
Biotechnology, Health Care, Medical, Wellness
Social Profiles
Canonical: https://fsome.com/organization/first-wave-bio-22955 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.